Cargando…

PReS-FINAL-2014: Excellent results of the conventional treatment in a child with late-diagnosed juvenile dermatomyositis with severe calcinosis

Detalles Bibliográficos
Autores principales:	Nikishina, IP, Arsenyeva, SV, Shapovalenko, AN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044270/ http://dx.doi.org/10.1186/1546-0096-11-S2-P27

Ejemplares similares

PReS-FINAL-2061: Abatacept in therapy of juvenile idiopathic arthritis in real clinical practice
por: Arsenyeva, SV, et al.
Publicado: (2013)

PReS-FINAL-2076: Single centre experience of biologics in clinical practice of systemic juvenile idiopatic arthritis
por: Kaleda, MI, et al.
Publicado: (2013)

PReS-FINAL-2013: Sodium thiosulfate for the treatment of Juvenile Dermatomyositis complicated by calcinosis
por: Pagnini, I, et al.
Publicado: (2013)

PReS-FINAL-2131: Hunting for biomarkers in juvenile dermatomyositis
por: Bellutti Enders, F, et al.
Publicado: (2013)

Calcinosis Universalis in Juvenile Dermatomyositis
por: Chung, Chong Hyuk
Publicado: (2020)

PReS-FINAL-2062: The need for conducting different rehabilitation complexes for patients with juvenile idiopathic arthritis (JIA)
por: Shelepina, TA, et al.
Publicado: (2013)

Treatment of calcinosis with biphosphonates in juvenile dermatomyositis
por: Bilginer, Y, et al.
Publicado: (2008)

PReS-FINAL-2008: Juvenile dermatomyositis: a report of 22 cases
por: Souto, A, et al.
Publicado: (2013)

Calcinosis as a complication of juvenile dermatomyositis (JDM)
por: Clara, Malagón, et al.
Publicado: (2011)

Calcinosis in juvenile dermatomyositis: Updates on pathogenesis and treatment
por: Pinotti, Caitlan S., et al.
Publicado: (2023)

PReS-FINAL-2060: The role of stress factors in the onset of juvenile idiopathic arthritis
por: Stepanenko, N, et al.
Publicado: (2013)

PReS-FINAL-2010: Predictive value of whole-body MRI in juvenile dermatomyositis
por: Malattia, C, et al.
Publicado: (2013)

PReS-FINAL-2012: Introducing a new approach to clinical care of juvenile dermatomyositis: the juvenile dermatomyositis multidimensional assessment report
por: Varnier, GC, et al.
Publicado: (2013)

PReS13-SPK-1030: Juvenile dermatomyositis
por: Quartier, P
Publicado: (2013)

Tumoral Calcinosis as an Initial Complaint of Juvenile-Onset Amyopathic Dermatomyositis
por: Doh, Eun Jin, et al.
Publicado: (2016)

46 Universal calcinosis in juvenile dermatomyositis: a case report
por: Bahaz, N, et al.
Publicado: (2022)

Growth retardation in patients with juvenile idiopathic arthritis and growth hormone therapy
por: Nikishina, I, et al.
Publicado: (2008)

Pres-FINAL-2009: Pediatric rheumatology practitioners experience with biologics in juvenile dermatomyositis: survey results
por: Patwardhan, A, et al.
Publicado: (2013)

An experience of sequental use of three biologics and recombinant growth hormone in a patient with juvenile idiopathic arthritis associated with unsuccessful outcome of hip damage
por: Nikishina, IP, et al.
Publicado: (2011)

Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis
por: Gunawardena, H, et al.
Publicado: (2009)

Clinical phenotypes and biologic treatment use in juvenile dermatomyositis-associated calcinosis
por: Orandi, Amir B., et al.
Publicado: (2018)

Role of mitochondria in the myopathy of juvenile dermatomyositis and implications for skeletal muscle calcinosis
por: Duvvuri, Bhargavi, et al.
Publicado: (2023)

PReS-FINAL-2129: Whole-body versus localized magnetic resonance imaging in the assessment of juvenile dermatomyositis
por: Madeo, A, et al.
Publicado: (2013)

PReS-FINAL-2011: Preliminary validation of a new hybrid measure of muscle strength for juvenile dermatomyositis
por: Marafon, D, et al.
Publicado: (2013)

PReS-FINAL-1014: Role of MHC class I overexpression on muscle biopsy of patients with juvenile dermatomyositis
por: Sanchez-Manubens, J, et al.
Publicado: (2013)

PReS-FINAL-2016: Bone mineral status in a long-term follow up of juvenile dermatomyositis patients
por: Kristensen, VA, et al.
Publicado: (2013)

PReS-FINAL-1020: Dysregulation of the peripheral blood D cell compartment is associated with disease activity in juvenile dermatomyositis
por: Piper, C, et al.
Publicado: (2013)

Efficacy of thalidomide in a girl with inflammatory calcinosis, a severe complication of juvenile dermatomyositis
por: Miyamae, Takako, et al.
Publicado: (2010)

Initial manifestations and risk factors for calcinosis in juvenile dermatomyositis: A retrospective multicenter study
por: Cakan, Mustafa, et al.
Publicado: (2023)

A family case of early onset juvenile idiopathic arthritis with uveitis: lessons of the past and the present
por: Nikishina, Irina, et al.
Publicado: (2014)

PReS-FINAL-2039: Evaluation of local activity of wrists and finger joints damage in patients with juvenile idiopathic arthritis: the values of radiology methods
por: Alekseev, D, et al.
Publicado: (2013)

Tocilizumab therapy in systemic juvenile idiopathic arthritis – lessons of real clinical practice
por: Kaleda, Maria I, et al.
Publicado: (2014)

PReS-FINAL-2015: Demographic, clinical and laboratory features of juvenile dermatomyositis in Croatia: retrospective study over the last 22 years
por: Frković, M, et al.
Publicado: (2013)

PReS-FINAL-2110: Tocilizumab for patients with oligoarticular juvenile idiopathic arthritis refractory to conventional therapy
por: Sato, T, et al.
Publicado: (2013)

Ten years of experience of biologics in juvenile idiopathic arthritis: focus for the reasons of withdrawals
por: Arsenyeva, Svetlana V, et al.
Publicado: (2014)

Calcinosis and lipodystrophy: clinical presentation of 10 years non-treated juvenile dermatomyositis – case report
por: Velma, Selmanovic-Mulaosmanovic, et al.
Publicado: (2011)

Muscular Weakness with Calcinosis Cutis_A Case of Juvenile Dermatomyositis in a South Asian Male
por: Khan, Qaisar Ali, et al.
Publicado: (2023)

A case of adult dermatomyositis with calcinosis universalis
por: Jayanthi, Mohan Roop, et al.
Publicado: (2014)

PReS-FINAL-2130-A: Effectiveness of intravenous cyclophosphamide in severe or refractory juvenile dermatomyositis - a national cohort study UK and Ireland
por: Moraitis, E, et al.
Publicado: (2013)

Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset
por: Tansley, Sarah L., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_n5mjh5msu18crhn7b8rii4dnbk